schliessen

Filtern

 

Bibliotheken

8.

Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacy.
by Van Looy, Thomas

Clinical cancer research : an official journal of the American Association for Cancer Research, December 1, 2014, Vol.20(23), pp.6071-6082

11.

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
by Weisberg, Ellen

Weisberg, Ellen, Martin Sattler, Paul W Manley, and James D Griffin. 2018. “Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy.” OncoTargets and therapy 11 (1): 175-182. doi:10.2147/OTT.S127679. http://dx.doi.org/10.2147/OTT.S127679.

13.

Inhibition of the human P2X 7 receptor by a novel protein tyrosine kinase antagonist
by Shemon, Anne N

Biochemical and Biophysical Research Communications, 2008, Vol.365(3), pp.515-520

20.

Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition
by Weisberg, Ellen L.

Weisberg, Ellen L., Martin Sattler, Abdel Kareem Azab, Dirk Eulberg, Anna Kruschinski, Paul W. Manley, Richard Stone, and James D. Griffin. 2017. “Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition.” Oncotarget 8 (66): 109973-109984. doi:10.18632/oncotarget.22409. http://dx.doi.org/10.18632/oncotarget.22409.

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 131 Hits